Valneva SE Share Price Borsa Italiana
Stocks
4VLA
FR0004056851
Biotechnology & Medical Research
OTC Markets Traded|
Real-time Estimate
Tradegate
11:00:15 02/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 2.621 EUR | -3.39% |
|
+1.65% | -27.58% |
| Market Cap | 50Cr 56Cr 46Cr 42Cr 79Cr 5.37TCr 81Cr 560.2Cr 216.86Cr 2.73TCr 209.31Cr 204.77Cr 8.78TCr | P/E 2026 * |
-5.99x | P/E 2027 * | 9.45x |
|---|---|---|---|---|---|
| Enterprise Value | 63Cr 71Cr 59Cr 54Cr 100.9Cr 6.82TCr 102.28Cr 711.48Cr 275.42Cr 3.47TCr 265.84Cr 260.07Cr 11TCr | EV / Sales 2026 * |
4.16x | EV / Sales 2027 * | 1.97x |
| Free-Float |
89.26% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Euronext Paris
| VLA | Real-time | |
CBOE
| VLAt | Real-time | |
|
Tradegate
| AYJ | Real-time | |
|
Xetra
| AYJ | Delayed | |
|
Boerse Muenchen
| AYJ | Real-time | |
|
Börse Stuttgart
| AYJ | Delayed | |
|
Wiener Boerse
| VLA | End-of-day quote | |
|
Deutsche Boerse AG
| AYJ | Delayed | |
|
OTC Markets
| INRLF | Delayed | |
|
CBOE
| 0OB3 | Real-time | |
|
Borsa Italiana
| 4VLA | End-of-day quote |
Last Transcript: Valneva SE
| 1 day | -3.39% | ||
| 1 week | +1.65% | ||
| Current month | -0.07% | ||
| 1 month | -3.83% | ||
| 3 months | +20.47% | ||
| 6 months | -3.79% | ||
| Current year | -27.58% |
| 1 week | 2.62 |  | 2.77 |
| 1 month | 2.62 | | 3.02 |
| Current year | 2.11 | | 5.05 |
| 1 year | 2.11 | | 5.05 |
| 3 years | 1.77 | | 6.37 |
| 5 years | 1.77 | | 28.02 |
| 10 years | 1.77 | | 28.02 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 62 | - | |
Peter Buhler
DFI | Director of Finance/CFO | 56 | 29/07/2021 |
| Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 62 | 20/12/2023 | |
James Sulat
BRD | Director/Board Member | 75 | 07/03/2013 |
| Chairman | 65 | 20/12/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.39% | +1.65% | - | - | 56Cr | |
| +4.16% | +3.04% | +49.37% | +94.17% | 7.44TCr | |
| -0.61% | +0.81% | +27.25% | +82.72% | 5.93TCr | |
| -2.54% | -1.65% | +4.86% | +31.72% | 4.71TCr | |
| -3.02% | -5.20% | +27.94% | +32.51% | 4.29TCr | |
| +0.31% | +3.02% | +348.95% | +643.82% | 4.41TCr | |
| -1.96% | -0.33% | +7.04% | +99.46% | 4.08TCr | |
| +3.32% | +3.49% | +10.10% | +51.23% | 3.08TCr | |
| -3.57% | +2.26% | +28.80% | +21.93% | 2.93TCr | |
| -4.86% | -10.66% | -26.27% | +330.06% | 2.37TCr | |
| Average | -1.19% | -0.52% | +53.12% | +154.18% | 4.36TCr | |
| Weighted average by Cap. | -0.39% | -0.32% | +58.44% | +146.05% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 15Cr 17Cr 14Cr 13Cr 24Cr 1.64TCr 25Cr 170.84Cr 66Cr 833.64Cr 64Cr 62Cr 2.68TCr | 28Cr 32Cr 26Cr 24Cr 45Cr 3.07TCr 46Cr 320.58Cr 124.1Cr 1.56TCr 119.78Cr 117.18Cr 5.02TCr |
| Net income | -8.11Cr -9.13Cr -7.59Cr -6.91Cr -13Cr -879.28Cr -13Cr -92Cr -36Cr -447.81Cr -34Cr -34Cr -1.44TCr | 5.31Cr 5.98Cr 4.96Cr 4.52Cr 8.51Cr 575.3Cr 8.63Cr 60Cr 23Cr 292.99Cr 22Cr 22Cr 941.07Cr |
| Net Debt | 13Cr 15Cr 13Cr 11Cr 21Cr 1.45TCr 22Cr 151.28Cr 59Cr 738.21Cr 57Cr 55Cr 2.37TCr | 6.25Cr 7.03Cr 5.84Cr 5.32Cr 10Cr 677.25Cr 10Cr 71Cr 27Cr 344.91Cr 26Cr 26Cr 1.11TCr |
| Date | Price | Change |
|---|---|---|
| 29/26/29 | €2.713 | -2.20% |
| 01/26/01 | €2.624 | -3.35% |
| 30/26/30 | €2.715 | +0.07% |
| 29/26/29 | €2.713 | -2.20% |
| 28/26/28 | €2.774 | +4.68% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- VLA Stock
- 4VLA Stock
Select your edition
All financial news and data tailored to specific country editions
